Saltoro Capital’s ENDRA Life Sciences NDRA Stock Holding History

Saltoro Capital’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6	Closed	-$145K	–	136
2020 Q4	$145K	Buy	+6	New	+$160K	0.07%	106

Other funds holding NDRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

55I LLC Boston, Massachusetts $3.58B AUM 17.97% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Saltoro Capital's NDRA Position: Q1 2021 in Review

Saltoro Capital sold out of ENDRA Life Sciences (NDRA) in Q1 2021, closing a stake of 6 shares — an estimated $145K sold.

Saltoro Capital first reported a position in NDRA in Q4 2020 and held it in 1 quarter. The position peaked at $145K in Q4 2020. 12 funds tracked by Wall St. Rank hold NDRA as of Q1 2021.

Saltoro Capital reported no remaining ENDRA Life Sciences position as of Q1 2021 after selling out during the quarter.
Saltoro Capital sold 6 ENDRA Life Sciences shares in Q1 2021, an estimated $145K.
Saltoro Capital first reported a position in ENDRA Life Sciences in Q4 2020 and held it in 1 quarter.
Saltoro Capital's ENDRA Life Sciences position peaked at $145K in Q4 2020.
12 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2021.

Based on Saltoro Capital's 13F filing for Q1 2021, filed 14 May 2021.